Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial

Year of publication

2023

Authors

Mummery CJ; Börjesson-Hanson A; Blackburn DJ; Vijverberg EG; De Deyn PP; Ducharme S; Jonsson M; Schneider A; Rinne JO; Ludolph AC; Bodenschatz R; Kordasiewicz H; Swayze EE; Fitzsimmons B; Mignon L; Moore KM; et al.

Organizations and authors

Turku University Central Hospital

Rinne Juha

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal/Series

Nature Medicine

Volume

Issue

Pages

1437-1447

ISSN

1078-8956

Publication forum

63771

Publication forum level

Open access

Open access in the publisher’s service

Self-archived

Other information

Fields of science

Neurology and psychiatry

Internationality of the publisher

International

International co-publication

Yes

Co-publication with a company

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes